| 标题 |
3-year invasive disease-free survival with chemotherapy de-escalation using an 18F-FDG-PET-based, pathological complete response-adapted strategy in HER2-positive early breast cancer (PHERGain): a randomised, open-label, phase 2 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet 作者:José Manuel Pérez-García; Javier Cortés; Manuel Ruíz‐Borrego; Marco Colleoni; Agostina Stradella; et al 出版日期:2024-04-01 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)